InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,304.72
(
0.70%
)
US TECH 100
18,318.00
(
0.95%
)
Dow Jones
39,069.59
(
0.01%
)
Brent Oil
81.97
(
0.00%
)
Bitcoin
69,312.97
(
0.06%
)
Post# of 251939
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

rfj1862

Send PM Follow Ignore
Followers 39
Posts 1714
Boards Moderated 0
Alias Born 10/05/2005

rfj1862

Re: Whalatane post# 247029

Wednesday, 05/17/2023 4:25:26 PM

Wednesday, May 17, 2023 4:25:26 PM

Post# of 251939

Cio / Dew Have either of you looked at OMER's Narsoplimab ( OMS721) for Iga Nephropathy
P3 9 mth data due Q3



Seems like the IgAN space is getting a little crowded.

Also narsoplimab inhibits the lectin pathway of complement. While the lectin pathway is involved, IgAN is predominantly driven by alternative pathway activation.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up